Ginkgo Bioworks
DNA
DNA
165 hedge funds and large institutions have $375M invested in Ginkgo Bioworks in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 35
0.76% more ownership
Funds ownership: 71.16% → 71.93% (+0.76%)
0% more funds holding
Funds holding: 165 → 165 (0)
Holders
165
Holding in Top 10
5
Calls
$22.1M
Puts
$9.64M
Top Buyers
| 1 | +$14M | |
| 2 | +$3.83M | |
| 3 | +$3.71M | |
| 4 |
Goldman Sachs
New York
|
+$3.53M |
| 5 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
+$3.18M |
Top Sellers
| 1 | -$8.34M | |
| 2 | -$5.38M | |
| 3 | -$3.24M | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$3.2M |
| 5 |
PP
PDT Partners
New York
|
-$2.45M |